Vontobel Holding’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.9K | Buy |
26,000
+4,000
| +18% | +$5.68K | ﹤0.01% | 1097 |
|
|
2025
Q1 | $33.7K | Buy |
22,000
+6,000
| +38% | +$9.18K | ﹤0.01% | 1077 |
|
|
2024
Q4 | $39.7K | Sell |
16,000
-4,000
| -20% | -$9.92K | ﹤0.01% | 1083 |
|
|
2024
Q3 | $23K | Hold |
20,000
| – | – | ﹤0.01% | 1071 |
|
|
2024
Q2 | $22K | Hold |
20,000
| – | – | ﹤0.01% | 1060 |
|
|
2024
Q1 | $24.8K | Sell |
20,000
-10,268
| -34% | -$12.7K | ﹤0.01% | 1070 |
|
|
2023
Q4 | $31.8K | Buy |
30,268
+17,040
| +129% | +$17.9K | ﹤0.01% | 1083 |
|
|
2023
Q3 | $90.6K | Sell |
13,228
-1,000
| -7% | -$6.85K | ﹤0.01% | 1024 |
|
|
2023
Q2 | $148K | Hold |
14,228
| – | – | ﹤0.01% | 1029 |
|
|
2023
Q1 | $115K | Buy |
+14,228
| New | +$115K | ﹤0.01% | 1022 |
|